Sign In
Buy NAUT
$2.58
-0.100 (-3.73%)
At Close: Jun 03, 2026
Nautilus to Participate in the Morgan Stanley Global Healthcare Conference
09:00am, Friday, 03'rd Sep 2021
SEATTLE, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the human p
Nautilus Biotechnology: Tapping The Potential Of The Human Proteome
02:54pm, Monday, 30'th Aug 2021
Nautilus Biotechnology seeks to deliver on the untapped potential of the human proteome.
Nautilus Biotechnology's (NAUT) CEO Sujal Patel on Q2 2021 Results - Earnings Call Transcript
12:33pm, Tuesday, 10'th Aug 2021
Nautilus Biotechnology's (NAUT) CEO Sujal Patel on Q2 2021 Results - Earnings Call Transcript
Nautilus Biotechnology Reports Second Quarter 2021 Financial Results
06:00am, Tuesday, 10'th Aug 2021
SEATTLE, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a life sciences company creating a platform technology for quantifying and unlocking the comp
Why Nautilus Biotechnology (NAUT) Stock Trading Higher Thursday?
03:23pm, Thursday, 05'th Aug 2021
Nautilus Biotechnology Inc (NASDAQ: NAUT) shares are trading higher during mid-day trading on Thursday following a CNBC report that Amazon.com Inc (NASDAQ: AMZN) held around $15 million stake in
Nautilus Biotechnology soars 65% after Amazon reveals a $15 million stake in the small-cap company
02:22pm, Thursday, 05'th Aug 2021
Nautilus is developing a platform that works to measure and identify the complexities of proteins, which could lead to drug discoveries.
Nautilus Biotechnology shares surge 50% on news of Amazon investment
01:48pm, Thursday, 05'th Aug 2021
Shares of Nautilus Biotechnology rose by as much as 50% on Thursday morning after a report revealed that Amazon has taken an equity stake in the newly public Seattle-based company.
Amazon discloses investment in biotech firm Nautilus
01:22pm, Thursday, 05'th Aug 2021
CNBC's Dominic Chu reports on an Amazon invetment of $14.7 million in Nautilus, a pre-revenue biotech firm.
